brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution
- RxCUI
- 861635
- RxNorm name
- brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution
- Display name
- brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution
- Full name
- brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Brimonidine Tartrate and Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Upsher-Smith Laboratories, LLC | b54e5bee-2329-4cc2-bed1-8eef11ee488c | 2026-06-18 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate and Timolol maleate Ophthalmic Solution | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Gland Pharma Limited | 038cf2ba-ad08-4981-a3cc-bff0e4ba5dfb | 2026-06-16 | Warnings, Adverse reactions | 861635 |
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Florida Pharmaceutical Products, LLC | 7011a203-46cf-434d-ba11-253f107ff80f | 2026-05-27 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate/Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Glenmark Pharmaceuticals Inc., USA | bf6a7f59-5a10-49fe-9e57-19e3ba202918 | 2026-05-06 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Apotex Corp. | 268c3f6b-8798-7987-3b8c-7b7f560af5d7 | 2026-04-23 | Warnings, Adverse reactions | 861635 |
| Brimonidine tartrate and Timolol maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | NorthStar RxLLC | be282a72-0797-449d-ae07-fb8d4bdcc0a5 | 2026-04-14 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate and Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Alembic Pharmaceuticals Inc. | 10e79593-b991-4899-89fd-6fff7a213d81 | 2026-04-01 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate and Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Sandoz Inc | af21d2e5-0029-4889-ba93-6417baa91ce6 | 2026-03-31 | Warnings, Adverse reactions | 861635 |
| COMBIGAN | BRIMONIDINE TARTRATE, TIMOLOL MALEATE | Allergan, Inc. | feaf1480-a4b8-4486-992a-96be3a596243 | 2026-03-17 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Leading Pharma, LLC | 533f9979-0cd7-485c-8c50-abbf717c5031 | 2025-05-30 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Caplin Steriles Limited | eac3cec2-b373-4936-89f0-c6d300e09f6e | 2025-03-10 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate and Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Somerset Therapeutics, LLC | e4fdbd17-73b7-49ed-9de3-591f36e0645d | 2024-10-14 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate/Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | ARMAS PHARMACEUTICALS INC | 09476aab-0816-812c-e063-6394a90a12a2 | 2023-11-03 | Warnings, Adverse reactions | 861635 |
| Brimonidine Tartrate and Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Alembic Pharmaceuticals Limited | b5d560b6-847e-4f09-b1ef-22e4deb8a206 | 2023-08-31 | Warnings, Adverse reactions | 861635 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| feaf1480-a4b8-4486-992a-96be3a596243 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 22 | These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | 20260317 |
| feaf1480-a4b8-4486-992a-96be3a596243 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 22 | These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | 20260317 |
| feaf1480-a4b8-4486-992a-96be3a596243 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 22 | These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | 20260317 |
| af21d2e5-0029-4889-ba93-6417baa91ce6 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 16 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260331 |
| af21d2e5-0029-4889-ba93-6417baa91ce6 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 16 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260331 |
| af21d2e5-0029-4889-ba93-6417baa91ce6 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 16 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260331 |
| 268c3f6b-8798-7987-3b8c-7b7f560af5d7 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 7 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For topical ophthalmic use Initial U.S. Approval: 2007 | 20260423 |
| 268c3f6b-8798-7987-3b8c-7b7f560af5d7 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For topical ophthalmic use Initial U.S. Approval: 2007 | 20260423 |
| 268c3f6b-8798-7987-3b8c-7b7f560af5d7 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 7 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For topical ophthalmic use Initial U.S. Approval: 2007 | 20260423 |
| b54e5bee-2329-4cc2-bed1-8eef11ee488c | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 5 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20241108 |
| b54e5bee-2329-4cc2-bed1-8eef11ee488c | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 5 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20241108 |
| b54e5bee-2329-4cc2-bed1-8eef11ee488c | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 5 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20241108 |
| 10e79593-b991-4899-89fd-6fff7a213d81 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 4 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. For Topical Administration Initial U.S. Approval: 2007 | 20250425 |
| 10e79593-b991-4899-89fd-6fff7a213d81 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 4 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. For Topical Administration Initial U.S. Approval: 2007 | 20250425 |
| 10e79593-b991-4899-89fd-6fff7a213d81 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. For Topical Administration Initial U.S. Approval: 2007 | 20250425 |
| 7011a203-46cf-434d-ba11-253f107ff80f | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260527 |
| 7011a203-46cf-434d-ba11-253f107ff80f | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260527 |
| 7011a203-46cf-434d-ba11-253f107ff80f | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260527 |
| bf6a7f59-5a10-49fe-9e57-19e3ba202918 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution 0.2%/0.5%, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260506 |
| bf6a7f59-5a10-49fe-9e57-19e3ba202918 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution 0.2%/0.5%, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260506 |
| bf6a7f59-5a10-49fe-9e57-19e3ba202918 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution 0.2%/0.5%, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260506 |
| e4fdbd17-73b7-49ed-9de3-591f36e0645d | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20241014 |
| e4fdbd17-73b7-49ed-9de3-591f36e0645d | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20241014 |
| e4fdbd17-73b7-49ed-9de3-591f36e0645d | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20241014 |
| be282a72-0797-449d-ae07-fb8d4bdcc0a5 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260414 |
| be282a72-0797-449d-ae07-fb8d4bdcc0a5 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260414 |
| be282a72-0797-449d-ae07-fb8d4bdcc0a5 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | 20260414 |
| 533f9979-0cd7-485c-8c50-abbf717c5031 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | 20250530 |
| 533f9979-0cd7-485c-8c50-abbf717c5031 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | 20250530 |
| 533f9979-0cd7-485c-8c50-abbf717c5031 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | 20250530 |
| eac3cec2-b373-4936-89f0-c6d300e09f6e | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | 20250310 |
| eac3cec2-b373-4936-89f0-c6d300e09f6e | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | 20250310 |
| eac3cec2-b373-4936-89f0-c6d300e09f6e | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | 20250310 |
| 09476aab-0816-812c-e063-6394a90a12a2 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20231103 |
| 09476aab-0816-812c-e063-6394a90a12a2 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20231103 |
| 09476aab-0816-812c-e063-6394a90a12a2 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | 20231103 |
| b5d560b6-847e-4f09-b1ef-22e4deb8a206 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. Brimonidine Tartrate and Timolol Maleate ophthalmic solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007. | 20230831 |
| b5d560b6-847e-4f09-b1ef-22e4deb8a206 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. Brimonidine Tartrate and Timolol Maleate ophthalmic solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007. | 20230831 |
| b5d560b6-847e-4f09-b1ef-22e4deb8a206 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. Brimonidine Tartrate and Timolol Maleate ophthalmic solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007. | 20230831 |
| 8c641b6c-3335-4ec3-89b9-2d97a8901062 | brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | 20110415 |
| 8c641b6c-3335-4ec3-89b9-2d97a8901062 | brimonidine tartrate 0.2 % / timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | 20110415 |
| 8c641b6c-3335-4ec3-89b9-2d97a8901062 | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | 20110415 |